Comparison between Agilus Diagnostics IPO and NSDL IPO.
Agilus Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while NSDL IPO is a Mainboard Bookbuilding proposed to list at BSE.
The total issue size of Agilus Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the NSDL IPO is up to ₹4,010.95 Cr. The final issue price of Agilus Diagnostics IPO is and of NSDL IPO is ₹800.00 per share.
| Agilus Diagnostics IPO | NSDL IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹760.00 per share | |
| Issue Price (Upper) | ₹800.00 per share | |
| Issue Price (Final) | ₹800.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ₹76.00 per share | |
| Market Lot Size | 18 shares | |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,42,33,964 shares | 5,01,45,001 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹4,010.95 Cr |
| Issue Size Total | 1,42,33,964 shares | 5,01,45,001 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹4,010.95 Cr |
Agilus Diagnostics IPO opens on , while NSDL IPO opens on Jul 30, 2025. The closing date of Agilus Diagnostics IPO and NSDL IPO is , and Aug 01, 2025, respectively.
| Agilus Diagnostics IPO | NSDL IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2025 | |
| Issue Open | Jul 30, 2025 | |
| Issue Close | Aug 01, 2025 | |
| Basis Of Allotment (Tentative) | Aug 04, 2025 | |
| Initiation of Refunds (Tentative) | Aug 05, 2025 | |
| Credit of Share (Tentative) | Aug 05, 2025 | |
| Listing date (Tentative) | Aug 06, 2025 | |
| Anchor Lockin End date 1 | Sep 02, 2025 | |
| Anchor Lockin End date 2 | Nov 01, 2025 |
Agilus Diagnostics IPO P/E ratio is , as compared to NSDL IPO P/E ratio of 46.63.
| Agilus Diagnostics IPO | NSDL IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)National Securities Depository Ltd.'s revenue increased by 12% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 46.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹16000.00 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.12% | 17.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.17% | 22.7% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.61% | 17.11% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Agilus Diagnostics IPO Retail Individual Investors (RII) are offered while in NSDL IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Agilus Diagnostics IPO and 1,00,12,000 shares in NSDL IPO.
| Agilus Diagnostics IPO | NSDL IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,50,17,999 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 1,00,12,000 shares | |
| NII | 75,09,001 shares | |
| RII | 1,75,21,001 shares | |
| Employee | 85,000 shares | |
| Others | ||
| Total | 5,01,45,001 shares |
Agilus Diagnostics IPO subscribed in total, whereas NSDL IPO subscribed 41.02x.
| Agilus Diagnostics IPO | NSDL IPO | |
|---|---|---|
| QIB (times) | 103.97x | |
| NII (times) | 34.98x | |
| Big NII (times) | 37.73x | |
| Small NII (times) | 29.47x | |
| RII (times) | 7.76x | |
| Employee (times) | 15.39x | |
| Other (times) | ||
| Total (times) | 41.02x |
